Human immunodeficiency virus type 1 (HIV-1) isolability, rate of replication, phenotype, plasma viremia, and specific intracellular transcripts were cross-sectionally analyzed in 61 HIV-1-seropositive individuals to evaluate the correlations between the virological and molecular correlates of protection and progression in different clinical subsets: recently infected subjects (RIs), long-term nonprogressors (LTNPs), late progressors (LPs), and typical progressors (Tps). Comparison of the major virological and molecular features of HIV-1 infection has defined distinct profiles for different subsets of patients, LTNPs or RIs, as well as LPs or TPs, exhibited similar titers of coculture p24 antigen; the differences between the former and the l...
The present thesis has undertaken two major areas of HIV pathogenesis for investigation. The first ...
Transition from long-term nonprogressive infection to progressive HIV-1 disease presents an opportun...
Background: Intervention with antiretroviral treatment (ART) and control of viral replication at the...
Virus load and virus phenotype have both been indicated as major determinants of disease progression...
A very small portion of the HIV-1 infected population is constituted by individuals, called long- te...
HIV -l-specific T -cell responses are preserved in HIV -1 infected individuals with non- progressing...
Background. Determinants of intersubtype differences in human immunodeficiency virus type 1 (HIV-1) ...
Long-term nonprogressive human immunodeficiency virus type 1 (HIV-1) infection and its transition to...
Neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates from 17 p...
Background: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
BACKGROUND. In a small percentage of persons infected with human immunodeficiency virus type 1 (HIV-...
Now that the acquired immunodeficiency syndrome (AIDS) epidemic is well into its second decade, it h...
BACKGROUND: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
HLA-B*5701 is the host factor most strongly associated with slow HIV-1 disease progression, although...
In the early days of the HIV epidemic, it was observed that a minority of the infected patients did ...
The present thesis has undertaken two major areas of HIV pathogenesis for investigation. The first ...
Transition from long-term nonprogressive infection to progressive HIV-1 disease presents an opportun...
Background: Intervention with antiretroviral treatment (ART) and control of viral replication at the...
Virus load and virus phenotype have both been indicated as major determinants of disease progression...
A very small portion of the HIV-1 infected population is constituted by individuals, called long- te...
HIV -l-specific T -cell responses are preserved in HIV -1 infected individuals with non- progressing...
Background. Determinants of intersubtype differences in human immunodeficiency virus type 1 (HIV-1) ...
Long-term nonprogressive human immunodeficiency virus type 1 (HIV-1) infection and its transition to...
Neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates from 17 p...
Background: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
BACKGROUND. In a small percentage of persons infected with human immunodeficiency virus type 1 (HIV-...
Now that the acquired immunodeficiency syndrome (AIDS) epidemic is well into its second decade, it h...
BACKGROUND: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
HLA-B*5701 is the host factor most strongly associated with slow HIV-1 disease progression, although...
In the early days of the HIV epidemic, it was observed that a minority of the infected patients did ...
The present thesis has undertaken two major areas of HIV pathogenesis for investigation. The first ...
Transition from long-term nonprogressive infection to progressive HIV-1 disease presents an opportun...
Background: Intervention with antiretroviral treatment (ART) and control of viral replication at the...